Montreal, QC (PRWEB) March 06, 2017
PharmaTech INNOVATION Inc., a fully integrated pharmaceutical company offering generic and proprietary drugs formulation and manufacturing, is pleased to announce that it has signed a Strategic Alliance Agreement with Labofine Inc., a fully certified Montreal-based company offering Analytical Testing and other services to the pharmaceutical, nutraceutical and cosmetics industries. Pursuant to the Agreement, PharmaTech INNOVATION and Labofine will work together to advance their respective business interests. In addition, Labofine will provide regulatory compliance consulting, logistics and quality control for PharmaTech INNOVATION Operations.
About Labofine Inc.
Labofine Inc. is an analytical services laboratory providing testing and quality control of pharmaceuticals, cosmetics and natural products. Labofine has a Drug Establishment License (DEL) from Health Canada to conduct licensable activities in a building which has been inspected and assessed as being in compliance with the requirements of Good Manufacturing Practices (GMP). All testing activities and other activities of Labofine meet the standards of Good Manufacturing Practice (GMP).
About PharmaTech INNOVATION Inc.
PharmaTech INNOVATION is a research driven company and is one of the operative divisions of Smart Medicines GMP Inc. PharmaTech INNOVATION focuses on research and development in pharmaceutical products and services as well as cosmetics, nutrition and medicinal herbs. Their expertise includes regulatory affairs and its toxicological, environmental and nano- and bio-technological considerations. As one of the operative arms of Smart Medicines GMP Inc., PharmaTech INNOVATION will benefit of 25 Million dollars investments to run its R&D Facility in Laval (Qc) over the next 4 years.